The growth of T lymphocyte colonies in agar is dependent on the cooperation of a number of different cell types and their products. Among these interacting cells are monocytes and/or macrophages. Monocytes are capable of producing both interleukin 1 (IL-1) and tumor necrosis factor (TNF). These two factors display a positive influence on T cell colony formation. Recombinant IL-1 and recombinant TNF were both shown to stimulate T cell colony growth in a dose-dependent manner, and this stimulation could be blocked by prior incubation with anti-IL-1 or anti-TNF, respectively. In addition, conditioned medium obtained from monocytes cultured in the presence of endotoxin also stimulated T cell colony formation. This stimulation by monocyte-conditioned medium was partially suppressed by incubation with anti-TNF or anti-IL-1, while incubation with both antibodies together displayed greater suppression. In conclusion, monocytes produce at least two factors, IL-1 and TNF, which can stimulate T cell colony formation by peripheral blood lymphocytes.
Introduction
The signals involved in the proliferation of T cells were originally studied using liquid culture techniques. These studies indicated the necessity for the elaboration of soluble growth factors and a requirement for cellular cooperation. In addition, these studies indicated that at least two signals were required for T cell growth (1, 2) . The in vitro growth of human T lymphocyte colonies has been shown to be dependent on the presence of a lymphokine produced by T lymphocytes and termed T cell growth factor or interleukin 2 (IL-2) (3). IL-2 is the product of a T cell subset which, in the presence of antigen or mitogen, becomes responsive to the monocyte product IL-l, which elicits the release of IL-2. Another subset of T lymphocytes acquires IL-2 receptors, and these cells proliferate in the presence of IL-2 (4) . Thus, T cell colony formation requires the cooperation betweenT lymphocyte colony-forming cells and a heterogeneous population ofhelper cells (5) (6) (7) (8) (9) (10) . The nature of these accessory cells is controversial and includes both T cells (7, 9) and monocytes (8, 10) . The exact role of these different cell populations and the nature of the factors they release that may be involved in T cell colony formation are still under investigation.
In the present study, we investigated the role of monocyte products on the stimulation of T cell colony formation by nonadherent, peripheral blood lymphocytes. Both recombinant IL-1 and human tumor necrosis factor (TNFa)' were shown to stimulate T cell colony formation by peripheral blood lymphocytes in a dose-dependent manner, and this stimulation could be suppressed by polyclonal anti-IL-l and anti-TNFa, respectively. In addition, medium conditioned by monocytes in the presence of endotoxin contained both IL-1 and TNFa. This monocyte-conditioned medium (MCM) also stimulated T cell colony formation in a dose-dependent manner. The stimulation by MCM was partially suppressed by prior incubation with anti-TNFa or anti-IL-1, while both antibodies together displayed greater suppression. Thus, monocytes produce at least two factors, namely IL-1 and TNFa, which are capable of stimulating T cell colony formation by peripheral blood lymphocytes.
Methods
Materials. TNFa was expressed in Escherichia coli and purified to homogeneity as was described previously (1 1). This material had 200 pg or less endotoxin per mg recombinant TNFa (rTNF) when assayed using the Limulus lysate assay. Human recombinant IL-I was also expressed in E. coli and purified by sequential ion-exchange chromatography and either gel-filtration or high performance liquid chromatography as previously described (12, 13) . Enzymatic digestion removed 41 amino acids of the precursor peptide, yielding IL-I with an NH2-terminus at position 112 and a molecular weight of 17,500. This recombinant form of IL-1 was homogeneous on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with an isoelectric point of 6.8-7.2 (14) .
Polyclonal antibodies to TNFa were a kind gift from Dr. Leo Lin (Cetus Corp., Emeryville, CA). Polyclonal antibodies to IL-1 were produced in rabbits and the IgG fraction obtained. These antibodies were capable of neutralizing TNFa and IL-1, respectively, and displayed no crossreactivity (1 1, 15) .
Isolation ofperipheral blood monocytes. Peripheral blood was obtained from normal donors who had given informed consent. Peripheral blood leukocytes were isolated after semi-continuous flow pheresis (16) . The buffy coat was diluted with 2 vol Hanks' balanced salt solution without calcium and magnesium and was centrifuged at 150 g for 10 min to remove platelets. This cell suspension was centrifuged over Ficoll-Hypaque (specific gravity 1.078) to remove contaminating granulocytes and erythrocytes. The mononuclear cells at the interface were collected and separated into two populations, monocytes and lymphocytes, by elutriation centrifugation as previously reported (13, 17, 18) . Briefly, counterflow centrifugation elutriation was performed using a Sanderson-designed separation chamber fitted into a Beckman model J-21C centrifuge. Up to 1.5 X 109 mononuclear cells were loaded into the chamber and elutriation was performed at 10C with flow rates of 18 and 28 ml/min against a force of 867 g (3,000 rpm). Each cell fraction was collected by centrifugation (300 g for 10 min) and the cell volume profile determined with an 80-pulse height analyzer (Particle Data, Inc., Elmhurst, IL). Using this technique, monocytes (380 Am3 modal volume) were collected as a homogeneous population. The separated monocytes were further subjected to 2-aminoethylisothiouronium bromide-treated sheep erythrocyte rosette depletion to remove contaminating T lymphocytes before use. Nonrosetting cells were separated by centrifugation through Ficoll-Hypaque. The purity of nonrosetting cells was determined using OKT3 monoclonal antibody and indirect immunofluorescence with fluoresceinconjugated goat anti-mouse IgG. The cells were analyzed using both fluorescence microscopy and a model C flow cytometer (Coulter Electronics, Inc., Hialeah, FL). Background staining was determined on cells treated with nonimmune mouse immunoglobulins and second antibody. In addition, the monocyte monoclonal antibody LeuM3 was used for analysis of monocyte specificity and compared with histological and histochemical staining for monocytes.
Monocytes were identified on cytocentrifuge-prepared slides stained with Wright's Giemsa and nonspecific esterase using alpha naphthyl acetate as substrate (19) . Nonspecific esterase-positive monocytes displayed a diffuse, cytoplasmic, red-brown reaction product. The monocyte populations used in all experiments described contained < 2% OKT3 positive and > 98% LeuM3 and > 98% nonspecific esterase-positive cells.
MCM studies. Various cell concentrations of separate fresh and cryopreserved monocyte populations were cultured for 2 d in alpha medium containing 5% fetal bovine serum. In some cultures, endotoxin (lipopolysaccharide B, Salmonella typhosa, Difco Laboratories, Inc., Detroit, MI) was added at the time of initiation of monocyte cultures. To produce MCM, monocytes were allowed to remain adhered to the dish and culture medium was added. The conditioned mediums were harvested, dialyzed, and stored frozen at -20°C until assay.
TNFa assay. The activity of TNFa was monitored by a previously described cell lytic assay (20) . Briefly, mouse L-929 fibroblasts were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. For assay, 0.1 ml containing 3 X I0O cells/ml were plated in each well of a 96-well culture plate to establish a dense monolayer. Dilutions of standard rTNFa or MCM were added in 0.5 ml vol together with 1 gg/ml actinomycin D. After 18 h of incubation at 37°C under 5% Co2, the samples were removed and the plates washed with phosphate-buffered saline. Cell lysis was detected by staining the plates with 0.5% crystal violet in methanol and water (1:4 vol/vol). The endpoint on the microtiter wells was determined by a Titertek multiscan autoreader (Flow Laboratories, Inc., McClean, VA) set for absorption at 550 nm. Cells exposed to culture medium alone represent 0% lysis, while those exposed to 3 M guanidine hydrochloride provide the 100% lysis end point.
Tcell colony assay. A modification ofthe whole blood method was used for human T cell colony formation in vitro (9, 21) . Briefly, peripheral blood was centrifuged over Ficoll-Hypaque (specific gravity 1.078) and the interface mononuclear cells collected. The mononuclear cells were depleted of monocytes by double adherence to culture plates for 1 h. The lymphocytes were counted and diluted in RPMI 1640 medium to obtain different concentrations of nucleated cells.
Irradiated (2,000 rad) red blood cells and granulocytes obtained from the pellet of the Ficoll/Hypaque centrifugation, different dilutions of monocyte-depleted peripheral blood mononuclear cells, and 56°C
heat-inactivated AB human serum were mixed with 1% low gel temperature agarose (Bio-Rad Laboratories, Richmond, CA) that had been warmed to 40'C and held at 370C until plating occurred. The final concentrations of 5-ml mixtures were 2.4% irradiated red blood cells containing -2 X 104/ml granulocytes, 20% heat-inactivated AB serum, 0.5% agarose, and different concentrations of monocyte-depleted peripheral blood mononuclear cells. l-ml aliquots of these mixtures were plated in quadruplicate in 6-well flat-bottom tissue culture plates containing 0.5 ml ofthe various test materials. In addition, each well was pulsed with 25 Ml phytohemmaglutinin-M (Difco Laboratories, Inc.). Colonies (aggregates of> 40 cells) were counted after 6 d of culture with the use of a projecting microscope (Bausch & Lomb Inc.) The total number of colonies per well was determined after four to six representative areas were counted in each well and the average number of colonies for the representative areas were corrected to reflect the total area of the well. Plating efficiency is the number of colonies per 101 lymphocytes plated. Significance was determined using Student's t test. In this culture system, irradiated red blood cells and granulocyte serve as a "feeder" layer, since these cells form no T cell colonies after 2,000 rad are given.
Neutralization studies. Human recombinant IL-1, TNFa, or MCM were incubated with anti-IL-1, anti-TNFa, or the IgG fraction of normal rabbit serum at 4VC overnight before addition to the T cell colony assay. As controls, anti-IL-l or anti-TNFa alone were also added to the T cell colony assay.
Results
T cell colony formation of nonadherent peripheral blood lymphocytes in vitro is dependent on the presence of IL-2 or on the ability to induce IL-2 in the culture system by a source of IL-I (Fig. 1 ). 1 U ofrecombinant IL-2, 200 ng/ml recombinant IL-1, or 10% conditioned medium from 106 monocytes/ml demonstrate a flat-line dose response in T cell colony formation between the lymphocyte plating concentrations of 0.88 and 5.00 X 104 nonadherent peripheral blood mononuclear cells which, in the present situation, contain -2% nonspecific esterase-positive cells. Figure 1 . Efficiency of T cell colony formation between the lymphocyte plating concentrations of 0.88 and 5.00 X 104 nonadherent (NA) peripheral blood mononuclear (PMN) cells. Effect of addition of 1 U recombinant IL-2 (rIL-2), 1 U recombinant IL-l (rIL-l), or 10% MCM. Data are presented from one of four representative experiments. CFU, colony-forming unit; RBC, red blood cells.
Effect of Interleukin I and Tumor Necrosis Factor 773
Addition of increasing concentrations of recombinant ILproduced a dose-dependent increase in T cell colony formation (Fig. 2 ). This increase could be blocked by prior incubation with anti-IL-I (P < 0.001). In fact, incubation with anti-IL-I alone produced a level of T cell colony inhibition below that seen when no stimulator was added (P < 0.001), indicating that anti-IL-I may be inhibiting endogenous IL-I present in the culture system.
TNFa is another product produced by activated human monocytes in culture (Table I ). The TNF produced by human monocytes in culture is completely inhibited by prior incubation with anti-TNFa, whereas anti-IL-I had no effect. Figs. 3 and 4 display the effects of recombinant TNFa on T cell colony formation in the presence and absence of 1 U of IL-2, respectively. rTNF demonstrated no effect on T cell colony growth when cultures were maximally stimulated with 1 U IL-2 ( Fig. 3) . Thus, TNFa did not directly suppress maximally stimulated T cell colony formation. In the absence of added IL-2 ( Fig. 4) , increasing concentrations of rTNF caused a dose-dependent increase in T cell colony formation that could be inhibited by prior incubation with anti-TNFa. Prior incubation of TNFa with anti-IL-i also appears to result in suppression ofT cell colony formation, suggesting that TNFa may exert its stimulatory influence through the action of IL-I (Fig.  5 ). However, this suppression of T lymphocyte colony formation may also arise due to anti-IL-I inactivation of IL-I en- 10, 000 2.5 LYMPHOCYTES X 104/ml Figure 4 . Influence of increasing concentrations of rTNF on the efficiency of T cell colony formation in the absence of added IL-2 when plating 1.25-5.00 X 104 lymphocytes/ml. Data are presented from one of three representative experiments. P < 0.001 when comparing control vs. 0.5-50 ng TNFa at 1.25 X 104 lymphocytes/ml. P < 0.00I when comparing 5 ng TNFa + anti-TNFa vs. 5 ng TNFa at 1.25 X 104 lymphocytes/ml. MCM was incubated with antibody to IL-i, antibody to TNFa, or antibody to both ILand TNFa before assaying for T cell colony formation. Fig. 6 indicates that while incubation of MCM with either anti-TNFa or anti-ILalone suppressed T cell colony formation, incubation of MCM with both anti-IL-I and anti-TNFa together gave the greatest suppression of T cell colony formation, suggesting that TNFa may exert its stimulatory influence independent of IL-1.
Discussion
The mechanisms regulating T cell colony formation in agarose from peripheral blood lymphocytes are poorly understood. Using excess exogenous IL-2 and performing cell dose-response curves, the number of T lymphocyte colony-forming cells per I0O lymphocytes plated can be determined. This num-ber reflects the proportion of T lymphocyte colony-forming cells present among peripheral blood lymphocytes and should result in a flat-line dose-response curve as seen in Fig. 1 . Plating cell dose-response curves in the absence of exogenous IL-2 requires not only the presence ofmitogen, but also ofIL-i, and results in the release ofIL-2. This occurs as a result ofcooperation among a number of different cell types within the colony culture system (9, 10, 22, 23) . These cell types include both helper and suppressor T cells and monocytes and/or macrophages. There have been contradictory reports concerning the role of monocytes in T cell colony formation. Some workers suppoit a positive influence on T cell colony growth (8, 10, 23) , while others (7, 24, 25) have implicated a suppressive role possibly due to their release of prostaglandins, which may inhibit colony growth. We have shown that the net regulatory role of macrophages (stimulatory or inhibitory) in T cell colony formation is dependent upon their concentration in culture (26) .
In the present study, we investigated the role oftwo known activated monocyte products (IL-I and TNFa) on T lymphocyte colony formation. MCM produced a dose-dependent increase in T cell colony formation that could be partially suppressed by either anti-TNFa or anti-IL-. Greater suppression occurred when both antibodies were used together, suggesting that MCM contained both IL-I and TNFa and that both of these materials were capable of stimulating T cell colony formation independent of each other. Whether TNFa directly stimulates the T colony-forming cell or whether it acts similarly to or via IL-I to stimulate helper T cells to produce IL-2, which then results in T colony formation, is not known at present. In addition, both recombinant IL-I and rTNF increased T cell colony formation in a dose-dependent manner when added to the culture system in the absence of exogenous IL-2. Their positive influence was suppressed when incubated with their respective antibodies before addition to the colony assay. TNFa-stimulated T cell colony formation was inhibited by anti-IL-i, suggesting that TNFa may stimulate IL-1 production by cells present in the T cell colony assay system. This effect of anti-IL-1 on TNFa stimulation was not due to crossreactivity by anti-IL-1, since no effect of anti-ILwas seen in the TNFa assay that used actinomycin D-treated L-929 cells (Table I) . However, suppression of TNFa-stimulated T cell colony formation by anti-IL-I may also be due to the presence of endogenous IL-I in the culture system. In any event the stimulation of IL-I production by TNFa is not without precedent, since TNFa has been reported to stimulate IL-I production by both monocytes (1 1, 27, 28 ) and endothelial cells (29, 30) . In addition, large granular lymphocytes (31) and B lymphocytes (32, 33) have also been reported to be capable of producing IL-1, and these cell populations are present in the nonadherent peripheral blood mononuclear cells used in the present study.
TNFa has also been reported to be associated with both stimulatory and inhibitory effects on in vitro hematopoietic progenitor cells (34) (35) (36) (37) . TNFa was shown to stimulate the production of granulocyte-macrophage colony-stimulating factor by fibroblasts and endothelial cells, thus displaying a positive influence on myeloid colony formation (34) (35) (36) . In the present report, a positive influence of TNFa was also shown for T lymphocyte colony formation. TNFa has been reported to demonstrate a suppressive influence on myeloid progenitor cell proliferation (37). However, in this study, no suppressive influence by TNFa on IL-2-stimulated T cell colony formation was seen (Fig. 3) . Therefore, we conclude that activated monocytes produce at least two products, IL-I and TNFa, which are capable of stimulating T cell colony formation. The exact action of TNFa is unknown at present. TNFa may exert its effect through the stimulation of IL-l by accessory cells present in the T cell colony assay system. It may also act independently of IL-I and stimulate IL-2 production by helper T cells or it may directly stimulate the T colony-forming cell. These possibilities are currently under investigation.
